Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene.
about
Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architectureExtracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factorScatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptorNormal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factorAlternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processingDisassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinaseIdentification and applications of repetitive probes for gene mapping in the mouse.The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cellsKeratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned mediumThe Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical AspectsInvasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.Epithelial differentiation of metanephric mesenchymal cells after stimulation with hepatocyte growth factor or embryonic spinal cord.Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factorExpression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenograftsOverexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.Signaling pathways in Ras-mediated tumorigenicity and metastasis.Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice.Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.Activating mutations for the met tyrosine kinase receptor in human cancer.Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factorThe mutationally activated Met receptor mediates motility and metastasis.Long-lasting molecular changes in human skin after repetitive in situ UV irradiation.Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74.Cooperative roles of hepatocyte growth factor and plasminogen activator in tubular morphogenesis by human microvascular endothelial cells.The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancerScatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation.
P2860
Q24338443-310C6987-E252-4A7A-AA24-D12D2304E19CQ24555664-ECC4A1FA-E5D7-471C-9753-C1F6544C9E55Q24564783-D37F5BBF-9708-4FC3-A397-45C248B9BD52Q28345285-FF3C1E9F-2973-4BD8-B322-C4B0D12DCB17Q33263389-F9D918B7-4DE4-4102-A542-C21EB15D0652Q33786959-8FF6419E-DBA8-47D3-82F4-5ADF6EF17982Q33943764-7C4FD962-7968-4A76-862B-5CA910923683Q33957428-F6881757-F0D1-4AFB-9B00-3BF44C9A1D24Q33959078-902223C6-5F99-4E8F-B6BB-76CFB0F5695FQ34171969-6D8CF5A2-4A24-433A-9028-C418EC2888F2Q35078950-1D00293A-3B2E-487A-A843-93DD85CB0C13Q35277738-407CE301-6C18-458D-9175-C7F3AEB56E01Q35427474-D3D86E0A-E255-48B0-8AFA-401E3F0E4FEBQ35796063-4EA1A844-0DD0-4716-8325-0483CFAB905FQ35961109-4964C6FE-373A-4598-B75D-18D609E33C61Q35975907-8C5F829A-2F80-470F-BBE4-FD595D95D174Q36136355-7432C3B3-C512-4108-80D3-05AE017F1FA4Q36219180-6B495F38-8B84-44A4-8A84-6C9CE00F0CA3Q36326357-B1F9B977-62A0-4D22-B0D5-FECFAAA914EFQ36427096-EABCF1BF-4405-43CD-8520-73B228CF8912Q36595980-96CEBBF1-876C-46C6-B38B-134D7B95F0C8Q36705281-077A8A19-D99B-4B16-B2AE-BB2737C6F467Q36735738-D128B34B-2452-4208-8156-8F9794A6A7D8Q37258139-95CDD7AB-A5F8-435D-ABCF-3AA311881604Q37356529-E27BFFA7-C3E2-42D6-BAFB-486AFD5BFD46Q38074430-4245951C-6E1B-45E6-85DF-DF389094FD64Q40472507-DEE2E548-B6F2-4D25-B021-9B8CEA2EAF8BQ41507260-BABD5EB9-BC81-4C93-B4FB-44EE724A01A1Q41563732-C5B44980-ABB9-47E2-835B-2F62097B3D97Q41870321-9C215ADF-4D32-4DCD-AD2C-9C4274250999Q41969702-7B2F6C08-ACC4-4A19-932E-A2E0260760F7Q42770153-C29A5611-EA0E-4475-81CD-640BB74C8AF1Q42821276-EC4ACC8A-1CA7-4030-96EC-E2569F829D3A
P2860
Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene.
description
1990 nî lūn-bûn
@nan
1990 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Structure, tissue-specific exp ...... f the mouse met protooncogene.
@ast
Structure, tissue-specific exp ...... f the mouse met protooncogene.
@en
type
label
Structure, tissue-specific exp ...... f the mouse met protooncogene.
@ast
Structure, tissue-specific exp ...... f the mouse met protooncogene.
@en
prefLabel
Structure, tissue-specific exp ...... f the mouse met protooncogene.
@ast
Structure, tissue-specific exp ...... f the mouse met protooncogene.
@en
P2093
P1476
Structure, tissue-specific exp ...... f the mouse met protooncogene.
@en
P2093
Bodescot M
Kmiecik TE
Vande Woude GF
P577
1990-02-01T00:00:00Z